It will not be one technology that changes how we address mental health, neurological disease and longevity. It will require the convergence of science, technology and story to create a new field of Immersive Medicine.
Next generation neurologic therapies will redefine what it means to be treated, blurring the lines between device, pharmaceutical and digital therapeutics.
New drugs will deliver medical devices (instead of the other way around), and media will guide healing, leaving us more biologically available for treatment and rapid recovery.
This is happening right now, in the companies, institutions and universities Samuel R. Browd, M.D., Ph.D. and I visited this week, led by an amazingly talented group of scientists, doctors, business and political leaders.
Thank you to everyone who made the last week so connected, productive and collaborative including:
(In order of last weeks meetings and accomplishments)
Russell R. Lonser, M.D. – Chair dept. Department of Neurological Surgery The Ohio State University & Director of the Gene Therapy Institute.
Michael Triplett PhD – Biotech Investor & Innovator, Chairman Armatus Bio, Inc.
Eddie Pauline, MBA, OhioCED – President and CEO Ohio Life Sciences
Craige Thompson, JD, EE, PE, Patent Attorney – Investor and founder of Thompson Patent Law Offices PC
Kyle Smith PhD, Board of Directors, DeepWell DTx, Reell Precision Manufacturing Corporation
Medical Devices Pathway & Jeff Harris Independent Neurological Regulatory Consultant.
Tim Lucas, MD, PhD, MHCI – CEO NeuroTech Institute
Dr. Daniel Donoho – Founder Surgical Data Science Collective (SDSC) & Digital Fluency
Erin McEachren – GM Enabling Technologies Medtronic
(Special thanks to Dominique Worthington, Kip Roberts, Jose Luis Rodriguez, Allen Hilton, Bob Reddy, Erik T.)
Special callout to Alan CohenDCVC, Daniel Kraft, MD, Continuum Health Ventures, Nichol Bradford, NIREMIA Collective, Scott Phillips, StarFish Medical, Gordy Bal, CTR Capital Fund, and Sam Englebardt, Galaxy Interactive who have helped define this new generation of “TechMedâ€, fueling the exponential growth our field is experiencing.
NeuFluent (including DeepWell DTx our Venture Studio in partnership with many of the amazing folks listed here, will be launching the Immersive Medicine Network – (https://lnkd.in/gW8M_vXN) a place for all this work to become more connected and accessible.
And we will again offer our conference series Digital Fluency – Digital Neurosurgery (Oct 31st – November 2nd – Palo Alto) in partnership with American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) with so much great partnership from Dr. Anthony (Tony) Asher and Katie Orrico.
Join us please and help take all these new initiatives and technologies to the next level. So much more to come!
